The NCCP National Guideline on the 'Diagnosis, staging and treatment of patients with oesophageal or oesophago-gastric cancer' is now available for consultation. A copy of the draft guideline and a feedback form are available here. Please complete the feedback form and return to email@example.com before the 8th January 2017.
National Clinical Guidelines
The Cancer Strategy 2006 recommended that national site-specific multi-disciplinary groups should be convened to develop evidence based guidelines for common cancers.
The National Cancer Control Programme (NCCP) is developing national evidence-based clinical guidelines for the diagnosis, staging and treatment of common cancers, through its "Guideline Development Groups" commencing with:
Evidence into practice - a rapid review.
- Aim to improve the quality of clinical care
- Aim to prevent variation in practice
- Are based on the best research evidence in conjunction with clinical expertise
- Are developed using clear methods that are sound, transparent, consistent, and command the respect of stakeholders, including the HSE, and regulatory authorities such as the Health Information and Quality Authority (HIQA)
Learn more about the methodology used for the development of NCCP Clinical Practice Guidelines.
Last updated 27th November 2017